Research Article
Prognostic Significance of Neutrophil/Lymphocytes Ratio (NLR) in Predicting Recurrence of Cervical Dysplasia
Table 3
Univariate and multivariate recurrence risk assessment.
| | Rec + | Rec - | Univariate | Multivariate |
| Age (years) | | | | | ≤30 | 23 | 73 | N.S. | — | 31-44 | 39 | 189 | ≥45 | 24 | 80 | NLR | | | | | <2 | 39 | 217 | | | ≥2 | 47 | 125 | OR (CI 95%): 2.09 (1.30–3.37) | OR (CI 95%): 2.41 (1.44–4.02) | Hr-HPV (post-LEEP) | | | | | Negative | 50 | 263 | | | Positive | 36 | 79 | OR (CI 95%): 2.40 (1.46–3.93) | OR (CI 95%): 3.00 (1.76–5.12) | Margins | | | | | Positive | 25 | 40 | | | Negative | 61 | 302 | OR (CI 95%): 3.42 (1.80–5.64) | OR (CI 95%): 3.53 (1.91–6.52) | Smoking | | | | | Yes | 37 | 139 | N.S. | — | No | 49 | 203 | | | E/P | | | | | Yes | 15 | 97 | | | No | 71 | 245 | | |
|
|
Rec = recurrence; N.S. = not significant.
|